Skip to content

Femoral or Sciatic Nerve Block to Provide Analgesia After Proximal Tibial Osteotomy

Femoral or Sciatic Nerve Block to Provide Analgesia After Proximal Tibial Osteotomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05728294
Enrollment
50
Registered
2023-02-15
Start date
2019-02-01
Completion date
2023-03-31
Last updated
2023-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Proximal tibial osteotomy is associated with moderate to severe postoperative pain. The proximal part of the tibia is innervated by branches from the femoral nerve anteriorly and the sciatic nerve posteriorly. Little is known on the type of peripheral nerve block to perform so that optimal postoperative analgesia is provided with minimum impact on the motor function. This randomised controlled double-blinded trial tested the hypothesis that a femoral nerve block provides superior analgesia than a sciatic nerve block after proximal tibial osteotomy.

Interventions

PROCEDUREFemoral nerve block with ropivacaine 0.5%, 20 ml

Femoral nerve block under ultrasound guidance with ropivacaine 0.5%, 20 ml

PROCEDURESciatic nerve block with ropivacaine 0.5%, 20 ml

Sciatic nerve block under ultrasound guidance with ropivacaine 0.5%, 20 ml

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Two groups: femoral nerve block or sciatic nerve block with ropivacaine

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* proximal tibial osteotomy

Exclusion criteria

* femoral or sciatic nerve deficit, * pre-existing peripheral neuropathy, * chronic pain diagnosis, * pregnancy, * identified contraindications to peripheral nerve block (e.g., local anesthetic allergy, coagulopathy, or infection at the block site).

Design outcomes

Primary

MeasureTime frameDescription
Intravenous morphine consumption24 hours after surgeryIntravenous morphine consumption (mg)

Secondary

MeasureTime frameDescription
Intravenous morphine consumption2 hours after surgeryIntravenous morphine consumption (mg)
rest pain score2 hours after surgerypain score at rest (visual analogue scale, 0-10)
dynamic pain score2 hours after surgerypain score on movement (visual analogue scale, 0-10)
Rate of postoperative nausea and vomiting2 hours after surgerynumber of events/total number of patients

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026